AlzeCure Pharma’s Nomination Committee for the 2021 Annual General Meeting

The Nomination Committee, which has been appointed in accordance with the principles adopted by the Annual General Meeting on May 20, 2020, consists of:

  • William Gunnarsson, appointed by BFCM P/C BFCM Sweden Retail FT
  • Bo Rydlinger, appointed by FV Group AB
  • Liselotte Jansson, appointed by AlzeCure Discovery
  • Thomas Pollare (Chairman of the Board)

The Nomination Committee shall, before the Annual General Meeting 2021, prepare decisions on election and remuneration issues and, where applicable, procedural issues for the next Nomination Committee.

Shareholders who wish to submit proposals to the Nomination Committee before the Annual General Meeting on May 12, 2021, can do so by e-mail to birgitta.lundvik@alzecurepharma.com. Proposals must be submitted to the Nomination Committee before 23 March 2021.

For further information, please contact:

Thomas Pollare, Chairman of the Board, AlzeCure Pharma AB
Mobil: +46(0)70-810 79 29
Email: thomas.pollare@alzecurepharma.com